TEVA FY 2022 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$37B

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$14.9B-6.0% YoY

Gross Profit

$7.0B46.7% margin

Operating Income

-$2.2B-14.7% margin

Net Income

-$2.4B-16.4% margin

EPS (Diluted)

$-2.20

Cash Flow

Operating Cash Flow

$1.6B

Free Cash Flow

$1.0B

Stock-Based Comp.

$124M

Balance Sheet

Total Assets

$44.0B

Total Liabilities

$35.4B

Stockholders' Equity

$7.8B

Cash & Equivalents

$2.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14.9B	$15.9B	-6.0%
Gross Profit	$7.0B	$7.6B	-8.2%
Operating Income	-$2.2B	$1.7B	-228.0%
Net Income	-$2.4B	$417M	-686.6%